Loading organizations...
Loading organizations...
Clinical-stage oncology company developing targeted cancer therapies.
Ayala Pharmaceuticals has raised $30.0M across 1 funding round.
Ayala Pharmaceuticals has raised $30.0M in total across 1 funding round.
Ayala Pharmaceuticals has raised $30.0M in total across 1 funding round.
Ayala Pharmaceuticals's investors include Novartis, Harel Insurance Investments & Financial Services, Israel Biotech Fund, SBI JI Innovation Fund.
Ayala Pharmaceuticals has raised $30.0M across 1 funding round. Most recently, it raised $30.0M Series B in May 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 28, 2019 | $30.0M Series B | Novartis | Harel Insurance Investments & Financial Services, Israel Biotech Fund, SBI JI Innovation Fund |